Collaborations with Life Sciences companies and academic organisations are a central component of our business strategy.

Collaborations with life sciences companies

AlgoNomics initiated several collaborations regarding vaccine development, therapeutic peptide discovery and the Immunoprofiling of therapeutic proteins.
These collaborations include:

• 4-Antibody AG: 4-Antibody AG has access to Epibase® technology for T-cell epitope identification.

• Ablynx NV: Ablynx and AlgoNomics have a research collaboration regarding the selection of antibody derived peptide leads.

• Alligator Bioscience: Alligator Bioscience AB addresses immunogenicity with Epibase® to maximally reduce immunogenicity upon optimization of protein therapeutics with Alligator's proprietary ssDNA recombination technology FIND®.

• BAC: BAC bv has access to AlgoNomics’ structural bioinformatics platform.

• Bayer Cropscience: AlgoNomics has entered into a research collaboration with Bayer Cropscience involving protein engineering and enzyme substrate modification.

• Bayer HealthCare: Bayer HealthCare AG has access to Epibase® technology for T-cell epitope profiling.

• CAT: Cambridge Antibody Technology Ltd. has access to Epibase® Technology for T-cell epitope profiling.

• Crucell: Crucell Ltd. has access to Epibase® Technology for T-cell epitope profiling.

• Centocor: Centocor, member of the Johnson & Johnson family of companies, has access to Epibase® Technology for T-cell epitope profiling.

• Evogenix Ltd.: Evogenix Ltd. has access to Epibase® Technology for T-cell epitope identification.

• Evolutec Ltd.: Evolutec Ltd. has access to Epibase® Technology for T-cell epitope identification.

• Genmab AS: AlgoNomics NV entered into an agreement granting Genmab A/S access to the Epibase® platform for T-cell epitope identification.

• GSK Biologicals: GSK Biologicals has access to Epibase® Technology for T-cell epitope identification.
• GSK R&D: GSK Research and Development has access to Epibase® Technology for T-cell epitope identification.

• Innogenetics NV: Innogenetics employs the Epibase® platform in the development of an Hepatitis C poly-epitope vaccine.

• Kirin Brewery: Kirin Brewery Ltd. has access to Epibase® technology for the immunoprofiling of therapeutic proteins.

• MAT Biopharma: MAT Biopharma SA and AlgoNomics entered into a research collaboration.
  AlgoNomics will employ its structural bioinformatics platform to assist MAT Biopharma in its research related to the structural analysis of its antibody leads
  

• Maxygen: Maxygen Inc. has access to Epibase® Technology for T-cell epitope identification.

• Pepscan Systems BV: Pepscan Systems announced positive results in the rational design of antibody binding peptides using our Tripole technology.
  The companies intend to exploit their “peptide-design-cycle” platform in the vaccination field.

• Peptech Ltd.: Peptech has access to Epibase® Technology for T-cell epitope identification.

• Pevion Biotech Ltd.: Pevion Biotech and AlgoNomics collaborate to rationally design RSV-derived peptides for use in vaccines.

• Pieirs AG: Pieris has access to Epibase® Technology for T-cell epitope identification.

• ProtAffin Biotechnologie AG: ProtAffin Biotechnologie has access to Epibase® Technology for T-cell epitope identification.

• Resistentia Pharmaceuticals AB: Resistentia Pharmaceuticals has access to Epibase® Technology for T-cell epitope identification.

• Syntaxin Ltd: Syntaxin has access to Epibase® Technology for T-cell epitope identification.

• Tibotec: AlgoNomics entered into a research collaboration with Tibotec, a subsidary of Johnson & Johnson, involving structural bioinformatics services on undisclosed targets.

• UCB Celltech: UCB Celltech has access to Epibase® Technology for T-cell epitope identification.

• Viragen: Viragen has access to Epibase® Technology for T-cell epitope identification.

Collaborations with academic groups

Academic collaborations were initiated with:

• Academic Medical Center (Amsterdam, NL)
• Institute of Tropical Medicine (Antwerp, BE)
• Laboratoire de retrovirologie (Luxembourg, LU)
• Leiden University Medical Centre LUMC (Leiden, NL)
• Medical Research Council (Cambridge, UK)
• Rega Institute (Leuven, BE)
• Université de Liége (Liége, BE)
• University of Texas (TX, USA)
• Vrije Universiteit Brussel (Brussels, BE)